• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经生长抑制因子-B 受体在相关癌中的研究进展:现状、挑战与目标(综述)。

Nogo‑B receptor in relevant carcinoma: Current achievements, challenges and aims (Review).

机构信息

Department of Histology and Embryology, Clinical Anatomy and Reproductive Medicine Application Institute, University of South China, Hengyang, Hunan 421001, P.R. China.

Department of Pharmacology, Hunan University of Medicine, Huaihua, Hunan 418000, P.R. China.

出版信息

Int J Oncol. 2018 Nov;53(5):1827-1835. doi: 10.3892/ijo.2018.4520. Epub 2018 Aug 9.

DOI:10.3892/ijo.2018.4520
PMID:30106141
Abstract

The novel neurite outgrowth inhibitor B (Nogo‑B) receptor (NgBR) is specific for Nogo‑B, which is highly expressed in various human organs and cells, including the lung, liver, kidney, smooth muscle cells, blood vessel endothelial cells and inflammatory cells. Previous studies have indicated that NgBR directly interacts with Nogo‑B and is able to independently influence lipid and cholesterol homeostasis, angiogenesis, N‑glycosylation, the epithelial-mesenchymal transition, the chemotaxis of endothelial cells and cellular proliferation and apoptosis. These multiple functions and actions of this receptor provide an understanding of the important roles of NgBR in various conditions, including fatty liver, atherosclerosis, intracranial microaneurysms, retinitis pigmentosa and severe neurological impairment. Furthermore, NgBR has been demonstrated to exert protean, multifunctional and enigmatic effects in cancer. The present review summarizes the latest knowledge on the suppressing and activating effects of NgBR, emphasizing its function in cancer. Further basic and medical research on this receptor may provide novel insight into its clinical implications on the prognosis of relevant human cancer types.

摘要

新型神经突生长抑制因子 B(Nogo-B)受体(NgBR)是 Nogo-B 的特异性受体,Nogo-B 在多种人类器官和细胞中高度表达,包括肺、肝、肾、平滑肌细胞、血管内皮细胞和炎性细胞。先前的研究表明,NgBR 可直接与 Nogo-B 相互作用,并能够独立影响脂质和胆固醇稳态、血管生成、N-糖基化、上皮-间充质转化、内皮细胞趋化性以及细胞增殖和凋亡。该受体的这些多种功能和作用为理解 NgBR 在包括脂肪肝、动脉粥样硬化、颅内微动脉瘤、色素性视网膜炎和严重神经损伤等各种情况下的重要作用提供了依据。此外,NgBR 已被证明在癌症中具有多样、多功能和神秘的作用。本综述总结了 NgBR 的抑制和激活作用的最新知识,强调了其在癌症中的功能。对该受体的进一步基础和医学研究可能为其在相关人类癌症类型的预后中的临床意义提供新的见解。

相似文献

1
Nogo‑B receptor in relevant carcinoma: Current achievements, challenges and aims (Review).神经生长抑制因子-B 受体在相关癌中的研究进展:现状、挑战与目标(综述)。
Int J Oncol. 2018 Nov;53(5):1827-1835. doi: 10.3892/ijo.2018.4520. Epub 2018 Aug 9.
2
Neurite Outgrowth Inhibitor B Receptor: A Versatile Receptor with Multiple Functions and Actions.神经突生长抑制因子B受体:一种具有多种功能和作用的多功能受体。
DNA Cell Biol. 2017 Dec;36(12):1142-1150. doi: 10.1089/dna.2017.3813. Epub 2017 Oct 23.
3
Activation of hepatic Nogo-B receptor expression-A new anti-liver steatosis mechanism of statins.他汀类药物激活肝 Nogo-B 受体表达——一种新的抗肝脂肪变性机制。
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Feb;1863(2):177-190. doi: 10.1016/j.bbalip.2017.12.002. Epub 2017 Dec 5.
4
Nogo-B receptor is essential for angiogenesis in zebrafish via Akt pathway.Nogo-B 受体通过 Akt 通路在斑马鱼血管生成中起关键作用。
Blood. 2010 Dec 9;116(24):5423-33. doi: 10.1182/blood-2010-02-271577. Epub 2010 Sep 2.
5
Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein.Nogo-B受体通过p53蛋白的泛素化促进人肝细胞癌的化疗耐药性。
Oncotarget. 2016 Feb 23;7(8):8850-65. doi: 10.18632/oncotarget.7091.
6
Research advances on neurite outgrowth inhibitor B receptor.神经突生长抑制因子 B 受体的研究进展。
J Cell Mol Med. 2020 Jul;24(14):7697-7705. doi: 10.1111/jcmm.15391. Epub 2020 Jun 15.
7
Nogo-B receptor deficiency increases liver X receptor alpha nuclear translocation and hepatic lipogenesis through an adenosine monophosphate-activated protein kinase alpha-dependent pathway.Nogo-B受体缺陷通过一种依赖于腺苷单磷酸激活的蛋白激酶α的途径增加肝脏X受体α的核转位和肝脏脂肪生成。
Hepatology. 2016 Nov;64(5):1559-1576. doi: 10.1002/hep.28747. Epub 2016 Aug 23.
8
Nogo-B Receptor Modulates Pulmonary Artery Smooth Muscle Cell Function in Developing Lungs.Nogo-B受体调节发育中肺脏的肺动脉平滑肌细胞功能。
Am J Respir Cell Mol Biol. 2016 Jun;54(6):892-900. doi: 10.1165/rcmb.2015-0068OC.
9
NOGOB receptor-mediated RAS signaling pathway is a target for suppressing proliferating hemangioma.NOGOB 受体介导的 RAS 信号通路是抑制增殖性血管瘤的靶点。
JCI Insight. 2021 Feb 8;6(3):142299. doi: 10.1172/jci.insight.142299.
10
NgBR is essential for endothelial cell glycosylation and vascular development.NgBR对内皮细胞糖基化和血管发育至关重要。
EMBO Rep. 2016 Feb;17(2):167-77. doi: 10.15252/embr.201540789. Epub 2016 Jan 11.

引用本文的文献

1
Loss of NgBR causes neuronal damage through decreasing KAT7-mediated RFX1 acetylation and FGF1 expression.NgBR的缺失通过降低KAT7介导的RFX1乙酰化和FGF1表达导致神经元损伤。
Cell Mol Life Sci. 2025 Apr 7;82(1):140. doi: 10.1007/s00018-025-05660-6.
2
Reducing Nogo-B Improves Hepatic Fibrosis by Inhibiting BACe1-Mediated Autophagy.抑制 BACE1 介导的自噬减少 Nogo-B 可改善肝纤维化。
Tissue Eng Regen Med. 2024 Jul;21(5):777-789. doi: 10.1007/s13770-024-00641-5. Epub 2024 Apr 17.
3
The Reticulon-4 3-bp Deletion/Insertion Polymorphism Is Associated with Structural mRNA Changes and the Risk of Breast Cancer: A Population-Based Case-Control Study with Bioinformatics Analysis.
网织红细胞蛋白4 3碱基对缺失/插入多态性与mRNA结构变化及乳腺癌风险相关:一项基于人群的病例对照研究及生物信息学分析
Life (Basel). 2023 Jul 12;13(7):1549. doi: 10.3390/life13071549.
4
O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma.SPOP的O-连接N-乙酰葡糖胺化促进肝细胞癌的致癌作用。
Oncogene. 2023 Mar;42(10):725-736. doi: 10.1038/s41388-022-02589-z. Epub 2023 Jan 5.
5
Nogo-B receptor increases glycolysis and the paclitaxel resistance of estrogen receptor-positive breast cancer via the HIF-1α-dependent pathway.Nogo-B 受体通过 HIF-1α 依赖性途径增加雌激素受体阳性乳腺癌的糖酵解和紫杉醇耐药性。
Cancer Gene Ther. 2023 May;30(5):647-658. doi: 10.1038/s41417-022-00542-6. Epub 2022 Oct 14.
6
miR-184-5p inhibits cell proliferation, invasion and predicts prognosis of clear cell renal cell carcinoma by targeting NUS1 dehydrodolichyl diphosphate synthase subunit: Results from large-scale comprehensive identification and validation.miR-184-5p通过靶向NUS1(去氢二萜醇二磷酸合酶亚基)抑制透明细胞肾细胞癌的细胞增殖、侵袭并预测其预后:大规模综合鉴定与验证结果
J Cancer. 2022 Feb 21;13(5):1398-1409. doi: 10.7150/jca.58053. eCollection 2022.
7
Activatable "Matryoshka" nanosystem delivery NgBR siRNA and control drug release for stepwise therapy and evaluate drug resistance cancer.可激活的“套娃”纳米系统递送NgBR小干扰RNA并控制药物释放以进行逐步治疗并评估耐药性癌症。
Mater Today Bio. 2022 Mar 19;14:100245. doi: 10.1016/j.mtbio.2022.100245. eCollection 2022 Mar.
8
Nogo-B promotes epithelial-mesenchymal transition in lung fibrosis via PERK branch of the endoplasmic reticulum stress pathway.Nogo-B通过内质网应激途径的PERK分支促进肺纤维化中的上皮-间质转化。
Ann Transl Med. 2021 Apr;9(7):563. doi: 10.21037/atm-20-6143.
9
Colorectal cancer (CRC) as a multifactorial disease and its causal correlations with multiple signaling pathways.结直肠癌(CRC)作为一种多因素疾病,其发生与多个信号通路密切相关。
Biosci Rep. 2020 Mar 27;40(3). doi: 10.1042/BSR20200265.